570 related articles for article (PubMed ID: 18721839)
1. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
Liu Y; Zhang S; Ma G; Zhang F; Hu R
Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
[TBL] [Abstract][Full Text] [Related]
2. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
[TBL] [Abstract][Full Text] [Related]
3. Canine adenovirus based rabies vaccines.
Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
[TBL] [Abstract][Full Text] [Related]
4. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
[TBL] [Abstract][Full Text] [Related]
5. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice.
Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B
Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine.
Henderson H; Jackson F; Bean K; Panasuk B; Niezgoda M; Slate D; Li J; Dietzschold B; Mattis J; Rupprecht CE
Vaccine; 2009 Nov; 27(51):7194-7. PubMed ID: 19925952
[TBL] [Abstract][Full Text] [Related]
8. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.
Bouet-Cararo C; Contreras V; Fournier A; Jallet C; Guibert JM; Dubois E; Thiery R; Bréard E; Tordo N; Richardson J; Schwartz-Cornil I; Zientara S; Klonjkowski B
Vaccine; 2011 Feb; 29(6):1304-10. PubMed ID: 21134446
[TBL] [Abstract][Full Text] [Related]
9. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein.
Hu R; Zhang S; Fooks AR; Yuan H; Liu Y; Li H; Tu C; Xia X; Xiao Y
Microbes Infect; 2006 Apr; 8(4):1090-7. PubMed ID: 16524754
[TBL] [Abstract][Full Text] [Related]
10. Rabies DNA vaccination by the intranasal route in dogs.
Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
[TBL] [Abstract][Full Text] [Related]
11. Experimental oral immunization of ferret badgers (Melogale moschata) with a recombinant canine adenovirus vaccine CAV-2-E3Δ-RGP and an attenuated rabies virus SRV9.
Zhao J; Liu Y; Zhang S; Fang L; Zhang F; Hu R
J Wildl Dis; 2014 Apr; 50(2):374-7. PubMed ID: 24506428
[TBL] [Abstract][Full Text] [Related]
12. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
13. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus].
Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ
Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263
[TBL] [Abstract][Full Text] [Related]
14. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
Lodmell DL; Esposito JJ; Ewalt LC
Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
[TBL] [Abstract][Full Text] [Related]
15. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
16. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
[No Abstract] [Full Text] [Related]
17. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
[TBL] [Abstract][Full Text] [Related]
19. Production, purification and analysis of an experimental DNA vaccine against rabies.
Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
[TBL] [Abstract][Full Text] [Related]
20. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
